Allurion amends notes/RIFAs with cash & revenue covenants, FDA/France deadlines; reports AUDACITY trial topline results

ALLURION TECHNOLOGIES, INC.

Omnibus Amendment imposes minimum cash balances and minimum trailing 12-month revenue tested quarterly starting Q3 2025.
Deadlines: French marketing authorization by Dec 31, 2025; FDA US marketing authorization by June 30, 2026.
Amendment fee: 5% fully-diluted shares to investors after $12M+ offering by Feb 15, 2025; else Series A-1 preferred redeemable Dec 31, 2026.
RTW gets second board seat; Jason Richey appointed to board alongside Nicholas Lewin.
Announced topline results from AUDACITY trial of Allurion Balloon; details in press release Exhibit 99.4.

item 1.01 item 2.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-003236
form_type: 8-K
ticker: ALUR
cik: 0001964979
company_name: ALLURION TECHNOLOGIES, INC.
filed_at: 2025-01-08T23:59:59+00:00
discovered_at: 2026-05-14T18:03:05.668727+00:00
generated_at: 2026-05-28T07:20:53.505543+00:00
sec_items: ["1.01", "2.02", "7.01", "9.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-003236
json_url: https://secwatch.observer/filing/0001193125-25-003236.json
markdown_url: https://secwatch.observer/filing/0001193125-25-003236.md
text_url: https://secwatch.observer/filing/0001193125-25-003236.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1964979/000119312525003236/0001193125-25-003236-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1964979/000119312525003236/d896057d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

MLTX

MoonLake aligns with FDA on BLA for sonelokimab in HS; Q1 cash $357.9M

MoonLake Immunotherapeutics May 11, 2026, 7:59 PM ET regulatory Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

REPL

Replimune to resubmit RP1 BLA for advanced melanoma; FDA agrees to prioritize review

Replimune Group, Inc. May 29, 2026, 9:56 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

SONM

DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider

DNA X, Inc. May 27, 2026, 4:35 PM ET regulatory Items 1.01, 2.03, 3.01, 3.02, 9.01

same SEC item: 1.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

VSTD

Vestand receives Nasdaq delisting notice for late quarterly and annual filings

Vestand Inc. May 26, 2026, 5:18 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

XHLD

TEN Holdings receives Nasdaq equity deficiency notice; issues 500k shares for $500k

TEN Holdings, Inc. May 26, 2026, 4:05 PM ET regulatory Items 1.01, 3.01, 3.02, 9.01

same SEC item: 1.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

MDAI

Spectral AI receives FDA De Novo clearance for DeepView System for burn indication

Spectral AI, Inc. May 26, 2026, 4:00 PM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

NVVE

Nuvve receives Nasdaq delisting notice for late Q1 10-Q filing; already under $1.00 bid price review

Nuvve Holding Corp. May 22, 2026, 6:35 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-25-003236

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.